IDEXX Laboratories (UK) Today
| 0J8P Stock | 431.44 1.10 0.25% |
Performance0 of 100
| Odds Of DistressLess than 1
|
IDEXX Laboratories is selling for under 431.44 as of the 18th of December 2024; that is 0.25% down since the beginning of the trading day. The stock's lowest day price was 429.21. IDEXX Laboratories has a very small chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 18th of November 2024 and ending today, the 18th of December 2024. Click here to learn more.
Business Domain Commercial & Professional Services | Classification Industrials |
IDEXX Laboratories is entity of United Kingdom. It is traded as Stock on LSE exchange. The company has 86.23 M outstanding shares. More on IDEXX Laboratories
Moving together with IDEXX Stock
Moving against IDEXX Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
IDEXX Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. IDEXX Laboratories' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding IDEXX Laboratories or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO President | Jonathan Mazelsky | ||||
| Business Concentration | Environmental & Facilities Services, Commercial & Professional Services, Industrials, Industrials, Commercial Services & Supplies, Commercial & Professional Services, Industrials (View all Sectors) | ||||
IDEXX Laboratories' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to IDEXX Laboratories' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
IDEXX Laboratories can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand IDEXX Laboratories' financial leverage. It provides some insight into what part of IDEXX Laboratories' total assets is financed by creditors.
| |||||
IDEXX Laboratories (0J8P) is traded on London Exchange in UK and employs 11,000 people. IDEXX Laboratories is listed under Environmental & Facilities Services category by Fama And French industry classification. The company currently falls under 'Mega-Cap' category with a current market capitalization of 3.74 T. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate IDEXX Laboratories's market, we take the total number of its shares issued and multiply it by IDEXX Laboratories's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. IDEXX Laboratories operates under Commercial Services & Supplies sector and is part of Industrials industry. The entity has 86.23 M outstanding shares.
IDEXX Laboratories generates positive cash flow from operations, but has no cash available
Check IDEXX Laboratories Probability Of Bankruptcy
Ownership AllocationIDEXX Laboratories has a total of 86.23 Million outstanding shares. The majority of IDEXX Laboratories outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in IDEXX Laboratories to benefit from reduced commissions. Thereupon, third-party entities are subject to a different set of regulations than regular investors in IDEXX Laboratories. Please pay attention to any change in the institutional holdings of IDEXX Laboratories as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check IDEXX Ownership Details
IDEXX Laboratories Risk Profiles
Although IDEXX Laboratories' alpha and beta are two of the key measurements used to evaluate IDEXX Laboratories' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.21 | |||
| Standard Deviation | 1.74 | |||
| Variance | 3.01 | |||
| Risk Adjusted Performance | (0.1) |
IDEXX Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in IDEXX Laboratories without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Insider Screener Now
Insider ScreenerFind insiders across different sectors to evaluate their impact on performance |
| All Next | Launch Module |
IDEXX Laboratories Corporate Management
Elected by the shareholders, the IDEXX Laboratories' board of directors comprises two types of representatives: IDEXX Laboratories inside directors who are chosen from within the company, and outside directors, selected externally and held independent of IDEXX. The board's role is to monitor IDEXX Laboratories' management team and ensure that shareholders' interests are well served. IDEXX Laboratories' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, IDEXX Laboratories' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sharon JD | General VP | Profile | |
| Sharon Underberg | General VP | Profile | |
| Michael Lane | Executive Technology | Profile | |
| George Fennell | Senior Officer | Profile |
Additional Tools for IDEXX Stock Analysis
When running IDEXX Laboratories' price analysis, check to measure IDEXX Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IDEXX Laboratories is operating at the current time. Most of IDEXX Laboratories' value examination focuses on studying past and present price action to predict the probability of IDEXX Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IDEXX Laboratories' price. Additionally, you may evaluate how the addition of IDEXX Laboratories to your portfolios can decrease your overall portfolio volatility.